BRIEF published on 07/24/2026 at 12:17, 3 months 18 days ago Invus Public Equities réduit sa participation dans MAAT PHARMA Droits De Vote Franchissement De Seuil Cession D'actions MaaT Pharma Invus
PRESS RELEASE published on 07/24/2026 at 12:12, 3 months 18 days ago Franchissement de seuils Déclaration de franchissement de seuils par Invus Public Equities, L.P. pour MAAT PHARMA sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuils MaaT Pharma Invus Public Equities
BRIEF published on 07/02/2026 at 18:35, 4 months 9 days ago Current status of MaaT Pharma shares and voting rights Euronext Paris Voting Rights Biotechnology Actions MaaT Pharma
BRIEF published on 07/02/2026 at 18:35, 4 months 9 days ago Situation actuelle des actions et droits de vote de MaaT Pharma Euronext Paris Droits De Vote Biotechnologie Actions MaaT Pharma
PRESS RELEASE published on 07/02/2026 at 18:30, 4 months 9 days ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital MaaT Pharma publie le nombre total d'actions et de droits de vote au 30 juin 2026 conformément à l'article 223-16 du Règlement Général de l'AMF Droits De Vote Capital Social AMF MaaT Pharma Biotechnologies
BRIEF published on 06/30/2026 at 13:13, 4 months 11 days ago La demande d'autorisation de mise sur le marché du MaaT013 de MaaT Pharma subit un revers. Maladie Du Greffon Contre L'hôte MaaT Pharma Décision Du CHMP Application Marketing Appel En Réexamen
BRIEF published on 06/30/2026 at 13:13, 4 months 11 days ago MaaT Pharma's Marketing Application for MaaT013 Faces Setback Graft-versus-Host Disease MaaT Pharma CHMP Decision Marketing Application Re-examination Appeal
PRESS RELEASE published on 06/30/2026 at 13:08, 4 months 11 days ago Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): Under review First Berlin Equity Research updates rating and price target for MaaT Pharma SACA after CHMP's negative opinion on MAA for MaaT013 in aGvHD First Berlin Equity Research CHMP AGvHD MaaT Pharma SACA MAA
BRIEF published on 06/26/2026 at 07:35, 4 months 15 days ago MaaT Pharma va contester le verdict négatif du CHMP concernant MaaT013 Thérapies Écosystémiques Du Microbiome MaaT Pharma Maladie Aiguë Du Greffon Contre L'hôte MaaT013 Xervyteg Réexamen CHMP
BRIEF published on 06/26/2026 at 07:35, 4 months 15 days ago MaaT Pharma to Challenge Negative CHMP Verdict for MaaT013 Microbiome Ecosystem Therapies MaaT Pharma Acute Graft-versus-Host Disease CHMP Re-examination MaaT013 Xervyteg
Published on 11/12/2026 at 01:40, 3 hours 26 minutes ago Nexteer Announces First Share Repurchase Programme of Up to US$60 Million
Published on 11/11/2026 at 23:30, 5 hours 36 minutes ago Faraday Copper Reports Third Quarter 2026 Financial Results and Announces Changes to the Board of Directors
Published on 11/11/2026 at 23:05, 6 hours 1 minute ago Vox Royalty Reports Q3 2026 Results and Declares Quarterly Dividend
Published on 11/11/2026 at 23:00, 6 hours 6 minutes ago CCL Industries Announces Appointment of New Director
Published on 11/11/2026 at 22:30, 6 hours 36 minutes ago 55 North Gold Qualifies for Trading on the OTCQB Venture Market and Launches New Corporate Website
Published on 11/12/2026 at 02:20, 2 hours 45 minutes ago Nanjing Offers a Window into the Yangtze River's Cultural Heritage and Renewal
Published on 11/11/2026 at 19:29, 9 hours 36 minutes ago EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 10 hours 24 minutes ago AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/10/2026 at 18:00, 1 day 11 hours ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 1 day 11 hours ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 1 day 11 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 1 day 11 hours ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
